Proposed Pharmacoeconomics Guideline p to Saudi Food & Drug ...

5. RESULTS5.1 Main results– Present all analyses in a step-by-step fashion, so thecalculations can be replicated if desired.– For both the technology and its comparator(s), the total costsand total benefits arising from their use should be presented– Final results should be based on increments (i.e., differencesbetween the intervention and alternatives) of expected costsand expected outcomes. The results for a CEA or CUAshould be reported as ICERs.– Provide tables of results in appendices; a visual display ofresults is encouraged.